Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer
High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer
Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer
Longterm Followup Finds Taxotere Improves Survival
Drug Combination Tested For B.C. Brain Metastases
Sunitinib May Be Associated With Cardiac Toxicity
BRCA Carriers Live Longer Than Those With Normal Gene
Rev/Vel/Dex Response Rate High In Phase I/II Study
FDA Approves Genetic Test For Breast Cancer Patients
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line
